| UPS | ubiquitin-proteasome system |
| ER | endoplasmic reticulum |
| ATG | Autophagy-related genes |
| FDA | Food and Drug Administration |
| IM | isolation membrane |
| ULK1 | Unc-51-like autophagy activating kinase 1 |
| PI3K | Phosphatidylinositide 3-kinase |
| mTORC1 | mechanistic target of rapamycin complex 1 |
| AMPK | AMP-activated protein kinase |
| MOM | Mitochondrial outer membrane |
| MOMP | MOM potential |
| ERES | ER exit sites |
| MAMs | mitochondria-associated ER membranes |
| PI3P | Phosphatidylinositol 3-phosphate |
| DFCP1 | double FYVE domain–containing protein 1 |
| Ubl | ubiquitin-like |
| LC3 | MT-associated protein 1 light chain 3 |
| LC3-PE | LC3-phosphatidylethanolamine |
| LIR | LC3 interacting regions |
| Ambra1 | Activating Molecule In Beclin1-Regulated Autophagy Protein 1 |
| p62/ SQSTM1 | Sequestosome-1 |
| MTs | Microtubules |
| ALR | autophagic lysosome regeneration |
| IP3R | inositol 1,4,5-trisphosphate (IP3) receptor |
| JNK | c-Jun N-terminal kinase |
| BH3 | Bcl-2 homology (BH) domain 3 |
| 3-MA | 3-methyladenine |
| MLCK | myosin light chain kinase |
| PLK1 | Polo-like kinase 1 |
| DNA-PK | DNA-dependent protein kinase |
| ATM | ataxia–telangiectasia mutated |
| NP | Nanoparticle |
| NCT | National Clinical Trial |
| PSM | Petrosaspongiolide M |
| EPI | Epirubicin |
| Bcl-2 | B-cell lymphoma 2 |
| TP | tea polyphenol |
| MTAs | MT-targeting agents |
| CA-4 | Combretastatin A-4 |
| CA-4P | CA-4 phosphate |
| NAC | N-acetyl cysteine |
| ROS | reactive oxygen species |
| rhArg | recombinant human arginase |
| 5-FU | 5-fluorouracil |
| VCP | Valosin Containing Protein or p97 |
| XN | xanthohumol |
| Sal A | salvianolic acid A |
| Sal B | salvianolic acid B |
| SCC | squamous cell carcinoma |
| CCC | circulating cancer cells |
| PTEN | phosphatase and tensin homolog deleted on chromosome 10 |
| EMT | epithelial-mesenchymal transition |
| AKT | protein kinase B (PKB) |
| HIF-1α | hypoxia-inducible factor 1α |
| VEGF | Vascular endothelial growth factor |
| HCC | hepatocellular carcinoma |
| CRC | colorectal cancer |
| Dox | Doxorubicin |
| Cdk4 | cyclin-dependent kinase 4 |
| Hsp-90 | heat shock protein-90 |
| PARP-1 | poly (ADP-ribose) polymerase 1 |
| ALL | acute lymphoblastic leukaemia |
| CQ | Chloroquine |
| Baf A1 | Bafilomycin A1 |
| OC | Oblongifolin C |
| GUTK | guttiferone K |
| v-ATPase | vacuolar-type ATPase |
| LMP | lysosomal membrane permeabilization |
| SAR | structure-activity relationship |
| CR | Caloric restriction |
| SIRT1 | Sirtuin 1 |
| BNIP3/BNIP3L | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3/ligand |
| STAT3 | Signal transducer and activator of transcription 3 |
| RAGE | receptor for advanced glycation end products |
| MDR1 | multidrug resistance protein 1 |
| P-gp | P-glycoprotein |
| NLRP3 | NLR family pyrin domain containing 3 |
| EGCG | (−)-epigallocatechin-3-gallate |
| CGA | chlorogenic acid |
| EGC | (−)-epigallocatechin |
| ECG | (−)-epicatechin-3-gallate |
| NSCLC | non-small cell lung cancer |
| MAPK | mitogen-activated protein kinase |
| N-CoR | nuclear receptor co-repressor |
| HSC70 | Heat shock cognate 71 kDa protein |
| TFEB | transcription factor EB |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| MMP | mitochondrial membrane potential |
| Nrf2 | Nuclear Factor, Erythroid 2 Like 2 |
| ARDs | age-related diseases |
| CRM | caloric restriction mimetic |
| p70S6K | phosphorylation of p70 ribosomal protein S6 kinase |
| SOCE | store operated calcium entry |
| TMZ | Temozolomide |
| MGMT | O6-methylguanine-DNA methyltransferase |
| TSC2 | Tuberous Sclerosis Complex 2 |
| PKC-δ | protein kinase C δ |
| TG2 | Transglutaminase |
| CSCs | cancer stem cells |
| 6-CEPN | 6-C-(E-phenylethenyl)naringenin |
| BUC | bladder urothelial carcinoma |
| PERK | phosphorylated extracellular signal-regulated kinase |
| eIF2α | Eukaryotic initiation factor 2α |
| CHOP | C/EBP homologous protein |
| CaMMK | Calmodulin- dependent kinase protein kinase |
| IRE1α | inositol-requiring enzyme 1α |
| TNBC | triple-negative breast cancer |
| MPT | mitochondrial permeability transition |
| SERCA | Sarcoplasmic-/ endoplasmic reticulum sarco/ER Ca2+ ATPase |
| TG | Thapsigargin |
| TBMS1 | Tubeimoside-1 |
| ERK1/2 | Extracellular signal-regulated kinase 1/2 |
| PTP1B | protein-tyrosine phosphatase 1B |
| DRP1 | dynamin-related protein |
| EEPP | ethanolic extract from P. polyphylla |
| DPPE | Diosgenin enriched P. polyphylla rhizome extract |
| BA | Betulinic acid |
| GRP78 | glucose-regulated protein 78 |
| CPT | Camptothecin |
| AP-1 | Activator protein 1 |
| miR-15a | microRNA-15a |
| BBR | Berberine |
| PDT | photodynamic therapy |
| TET | Tetrandrine |
| APL | acute promyelocytic leukemia |
| PA | pituitary adenoma |
| TRAIL | Tumor necrosis factor (TNF)-related apoptosis-inducing ligand |
| TRAF2 | TNF receptor-associated factor 2 |
| FAK | focal adhesion kinase |
| S6K1 | 70-kDa ribosomal S6 kinase 1 |
| TQ | Thymoquinone |
| GBM | glioblastoma multiforme |
| LXRα | liver-X receptors α |
| ABCA1 | ATP-binding cassette transporter A1 |
| ccRCC | clear cell renal cell carcinoma |
| AR | androgen receptor |
| ω3-PUFAs | omega-3 polyunsaturated fatty acids |
| EPA | eicosapentaenoic acid |
| EPADA | EPA-dopamine |
| DHA | docosahexaenoic acid |
| DHADA | DHA-dopamine |
| MM | multiple myeloma |
| PBMCs | peripheral blood mononuclear cells |
| DCs | dendritic cells |
| PPARγ | peroxisome proliferator-activated receptor γ |
| Delta-T3 | vitamin E Delta-tocotrienol |
| HDACIs | histone deacetylase inhibitors |
| TSA | trichostatin A |
| SAHA | suberoylanilide hydroxamic acid |
| FOXO1 | forkhead box protein1 |
| PRMT5 | protein arginine methyltransferase 5 |
| TRPV6 | transient receptor potential cation channel, subfamily V, member 6 |
| STC1 | stanniocalcin 1 |
| IGFBP2 | insulin-like growth factor (IGF) binding protein-2 |
| VSOAC | volume-sensitive organic anion channel |
| TauT | taurine transporter |
| MTP | mitochondrial transmembrane potential |
| CLL | Chronic Lymphocytic Leukaemia |
| ANT | Active, not recruiting |
| T | terminated |
| C | Completed |
| S | Suspended |
| R | Recruitment |
| NR | Not yet recruiting |
| U | Unknown |
| ATRA | all-trans retinoic acid |
| CyP | Cyclophosphamide |
| Cape | Capecitabine |
| PCOS | Polycystic ovarian syndrome |
| FME | familial Mediterranean fever |
| HEKs | human epidermal keratinocytes |
| CSCC | cutaneous squamous cell carcinoma cell |
| NTM | nontuberculous mycobacteria |
| LYNUS | lysosomal nutrient sensing machinery |